Tag: Sexually Transmitted Diseases: AIDS/HIV
UB-421 Monotherapy Maintains HIV Viral Suppression
Suppression maintained for up to 16 weeks in HIV-infected undergoing analytic treatment interruption
Nonalcoholic Fatty Liver Disease Burden Up Among HIV-Infected
NAFLD becoming increasingly important cause of liver disease, liver mortality
STI Incidence Up After Receipt of HIV Preexposure Prophylaxis
Younger age, greater partner number, group sex, but not condom use, linked to increased risk of STI
First Two-Drug Regimen Approved for HIV-1 Treatment
Dovato indicated for use in patients with no history of antiretroviral treatment
Depressive Symptoms May Up Risk for Death in HIV+ Veterans
However, depression linked to higher risk for death in HIV-uninfected, but not HIV-infected, U.S. veterans
AACR: HPV Vax Low for Adults at High Risk for HIV Infection
Age, sex, sexual orientation differences in HPV vaccination rates were statistically significant
Dolutegravir Feasible for HIV Tx in Women of Childbearing Age
Risk for neural tube defects offset by fewer deaths among women, decreased sexual HIV transmission
March 2019 Briefing – HIV & AIDS
Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for March 2019. This roundup includes...
CDC: New HIV Transmission Often From Those Unaware of Infection
Almost 80 percent of new transmissions from people not aware or aware but not receiving regular care
One-Month Regimen Noninferior for Preventing HIV-Related TB
One-month rifapentine, isoniazid noninferior to nine months of isoniazid alone
